Year in Review: Clinical Investigator Perspec...

Up next

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.CME information and select publications here.

. 51min 55sec

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Dr Andrew J Armstrong from the Duke Cancer Institute in Durham, North Carolina, and Dr Scott T Tagawa from Weill Cornell Medicine Meyer Cancer Center in New York, New York, discuss the selection and sequencing of therapy for patients with prostate cancer and summarize major advan ... Show more

. 58min 21sec

Recommended Episodes

18F-PSMA-1007 PET/CT - Sponsored by Mayo Clinic

Radiology Podcast | RSNA

Dr. Ashwin Singh Parihar discusses the role of multiparametric MRI and 18F-PSMA-1007 PET/CT for the detection of clinically significant prostate cancer with Dr. Bastiaan Privé. This episode is sponsored by Mayo Clinic. Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detectio ... Show more

. 18min 6sec

Professor Joël Guigay on clinical trials of older patients with head and neck cancer

The Lancet Healthy Longevity in conversation with

Joël Guigay discusses the ELAN-FIT and ELAN-UNFIT trials in older people with head and neck cancer, published in The Lancet Healthy Longevity, and the importance of geriatric assessments in clinical trials of older cancer patients.Read the full articles: https://www.thelancet.com/ ... Show more

. 34min 38sec

AUANewsWorthy Webinar: An Integrated Biomarker and MRI Risk Assessment Approach to Prostate Cancer Diagnosis

AUANews Inside Tract

Prostate cancer diagnostic guidelines aim to minimize over-diagnosis of clinically insignificant prostate cancer (Gleason6/GG1). The clinical question before us is how do we enable the best balance, helping to increase compliance with the biopsy recommendation for patients at hig ... Show more

. 51min 37sec

A Reassessment of Prostate Cancer Treatment (Live from the 2024 ASCO Annual Meeting)

Symptomatic: A Medical Mystery Podcast

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Join Lauren Bright Pacheco at the 2024 ASCO Annual Meeting in Chicago, as she investigates the advancements in prostate cancer care. Dr. Mohammad Atiq shares ways innovative treatments are paving the ... Show more

. 41min 41sec